Astra Healthcare Launches Cof BPD: First time in India

Astra Healthcare is excited to announce the launch of Cof BPD, a groundbreaking product that marks a first in the Indian market. Cof BPD is a combination syrup that brings together Bilastine, Dextromethorphan, and Phenylephrine in a refreshing mint flavor. This innovative formula is designed to provide relief from common cold and cough symptoms while ensuring a pleasant taste experience for users.

Key Features of Cof BPD:

• Bilastine: A powerful antihistamine that helps relieve allergy symptoms such as sneezing, runny nose, and itchy eyes.
• Dextromethorphan: A well-known cough suppressant that reduces the urge to cough.
• Phenylephrine: A decongestant that helps relieve nasal congestion and sinus pressure.

With its unique combination of ingredients, Cof BPD offers a comprehensive solution for managing cold and cough symptoms, making it an essential addition to every household’s medicine cabinet.

Innovation in Flavor:

Unlike many other cough syrups that can have a strong medicinal taste, Cof BPD comes in a refreshing mint flavor, making it more palatable and easier to consume for patients of all ages.

Availability:

Cof BPD is now available across pharmacies and healthcare institutions nationwide. Astra Healthcare remains committed to providing innovative healthcare solutions that cater to the needs of patients, ensuring both efficacy and user satisfaction.

Stay tuned for more updates from Astra Healthcare as we continue to push the boundaries of healthcare innovation.